2020 Environmental, Social and Governance Report
Extracted ESG KPIs
KPIs are organized by ESG aspects.
The types of emissions and respective emissions data.
| Indicator | Unit | 2020 | Report Pages |
|---|---|---|---|
| Ammonia nitrogen | Tonnes | 1.2 | 84 |
| Chemical oxygen demand CODcr | Tonnes | 20.12 | 84 |
| Pollutant emission compliance rate (wastewater, waste gas, powder, noise) | 100% | 48 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2020 | Report Pages |
|---|---|---|---|
| Greenhouse Gas Emission Intensity | Tonnes CO2e/RMB million | 18.11 | 57 |
| Greenhouse Gas Emissions | Tonnes CO2e | 42527.43 | 57 |
| Greenhouse gas emissions | tonnes CO2e | 42527.43 | 84 |
| Intensity of greenhouse gas emissions | Tonnes CO2e/revenue (RMB million) | 18.11 | 84 |
| Scope 1 Total Greenhouse Gas Emissions | Tonnes | 46.67 | 57 |
| Scope 1 Total greenhouse gas emissions | Tonnes | 46.67 | 84 |
| Scope 2 Total Greenhouse Gas Emissions | Tonnes | 42480.75 | 57 |
| Scope 2 Total greenhouse gas emissions | Tonnes | 42480.75 | 84 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Collection, standardized storage and disposal rate of industrial waste | 100% | 48 | ||
| Dichloromethane consumption | Tonnes | 429.86 | 353.35 | 85 |
| Intensity of hazardous wastes | Tonnes/revenue (RMB million) | 0.03 | 84 | |
| Other hazardous wastes | Tonnes | 49.99 | 84 | |
| Pharmaceutical waste | Tonnes | 28.7 | 84 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2020 | Report Pages |
|---|---|---|---|
| General industrial waste and domestic waste | Tonnes | 1737.51 | 84 |
| Intensity of non-hazardous wastes | Tonnes/revenue (RMB million) | 0.74 | 84 |
Description of how hazardous and non-hazardous wastes are handled, and a description of reduction target(s) set and steps taken to achieve them.
| Indicator | Unit | 2020 | Report Pages |
|---|---|---|---|
| Legal and standardized disposal rate of hazardous waste | 100% | 48 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Diesel | Litres | 19060 | 17880 | 85 |
| Ethanol consumption | Tonnes | 525.88 | 438.93 | 85 |
| Externally purchased power: Central China Grid | kWh | 33231342 | 5267284 | 85 |
| Externally purchased steam | Tonnes | 58294.48 | 50902.6 | 85 |
| Methanol consumption | Tonnes | 90.6 | 70.16 | 85 |
| Total energy consumption | Tonnes of standard coal | 11630.85 | 12991.35 | 85 |
| Total energy consumption intensity | Tonnes of standard coal/revenue (RMB million) | 1.86 | 5.53 | 85 |
| Total standard coal consumption (Group) | tonnes | 12991.35 | 59 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Freshwater consumption | Tonnes | 529377 | 1273174.3 | 85 |
| Industrial wastewater | Tonnes | 1064987.23 | 84 | |
| Total water consumption (Group) | tonnes | 1273174.3 | 59 |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Packaging materials used | Tonnes | 3116.7 | 2090.93 | 85 |
| Total packaging materials consumption for finished products (Group) | tonnes | 2090.93 | 59 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
| Indicator | Unit | 2019 | 2020 | 2021 | 2022 | Report Pages |
|---|---|---|---|---|---|---|
| Capitalised R&D investment amount for Furaprevir (Phase III clinical trial) | RMB'000 | 13412.41 | 36 | |||
| Capitalised R&D investment amount for Insulin Aspart 30 Injection | RMB'000 | 29795.58 | 37 | |||
| Capitalised R&D investment amount for Insulin Glargine Injection | RMB'000 | 16749.47 | 37 | |||
| Capitalised R&D investment amount for Isohpane Protamine Recombinant Human Insulin Injection (Pre-mixed 30R) | RMB'000 | 27383.85 | 37 | |||
| Investment in environmental governance and protection | RMB | 5295373 | 7143078 | 85 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Indicator | Unit | 2019 | 2020 | 2021 | 2022 | Report Pages |
|---|---|---|---|---|---|---|
| Employees aged 30-50 | Person | 3796 | 3296 | 86 | ||
| Employees aged 50 or above | Person | 62 | 74 | 86 | ||
| Employees below 30 years old | Person | 2354 | 1396 | 86 | ||
| Employees in Hubei province | Person | 1997 | 4478 | 86 | ||
| Employees in other regions in the PRC | Person | 4213 | 288 | 86 | ||
| Employees overseas | Person | 2 | 86 | |||
| Employees with associate education | Person | 2954 | 1702 | 86 | ||
| Employees with bachelor education | Person | 1938 | 1485 | 86 | ||
| Employees with master or above education | Person | 108 | 117 | 86 | ||
| Employees with vocational or below education | Person | 1212 | 1462 | 86 | ||
| Female employees | Person | 2467 | 2588 | 86 | ||
| Male employees | Person | 3745 | 2178 | 86 | ||
| Percentage of R&D investment in operating costs for Furaprevir (Phase III clinical trial) | % | 12.19 | 36 | |||
| Percentage of R&D investment in operating costs for Insulin Aspart 30 Injection | % | 8.44 | 37 | |||
| Percentage of R&D investment in operating costs for Insulin Glargine Injection | % | 5.06 | 37 | |||
| Percentage of R&D investment in operating costs for Isohpane Protamine Recombinant Human Insulin Injection (Pre-mixed 30R) | % | 7.99 | 37 | |||
| Percentage of R&D investment in operating income for Furaprevir (Phase III clinical trial) | % | 1.82 | 36 | |||
| Percentage of R&D investment in operating income for Insulin Aspart 30 Injection | % | 1.27 | 37 | |||
| Percentage of R&D investment in operating income for Insulin Glargine Injection | % | 0.76 | 37 | |||
| Percentage of R&D investment in operating income for Isohpane Protamine Recombinant Human Insulin Injection (Pre-mixed 30R) | % | 1.17 | 37 | |||
| Total number of employees | Person | 6212 | 4766 | 86 |
Employee turnover rate by gender, age group and geographical region.
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Employee turnover rate | % | 3.6 | 23.28 | 87 |
| Number of employee turnover in Central China | Person | 217 | 1347 | 87 |
| Number of employees turnover in other regions in the PRC | Person | 8 | 99 | 87 |
| Number of female employees turnover | Person | 101 | 742 | 87 |
| Number of male employees turnover | Person | 124 | 704 | 87 |
| Total number of employee turnover | Person | 225 | 1446 | 87 |
| Turnover number of employees aged 30–50 | Person | 83 | 636 | 87 |
| Turnover number of employees aged 50 or above | Person | 2 | 1 | 87 |
| Turnover number of employees aged below 30 | Person | 140 | 809 | 87 |
Number and rate of work-related fatalities occurred in each of the past three years including the reporting year.
| Indicator | Unit | 2019 | Report Pages |
|---|---|---|---|
| Number of work injuries | Times | 2 | 87 |
Lost days due to work injury.
| Indicator | Unit | 2019 | Report Pages |
|---|---|---|---|
| Lost days due to work injury | Days | 126 | 87 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Indicator | Unit | 2020 | 2021 | 2022 | Report Pages |
|---|---|---|---|---|---|
| Number of employees trained | 4766 | 67 | |||
| Number of entry-level employees trained | Person | 4338 | 88 | ||
| Number of female employees trained | Person | 2588 | 88 | ||
| Number of male employees trained | Person | 2178 | 88 | ||
| Number of senior management trained | Person | 56 | 88 | ||
| Percentage of entry-level employees trained | % | 91.02 | 88 | ||
| Percentage of female employees trained | % | 54.3 | 88 | ||
| Percentage of male employees trained | % | 45.7 | 88 | ||
| Percentage of mid-level management trained | % | 7.81 | 88 | ||
| Percentage of senior management trained | % | 1.17 | 88 | ||
| Percentage to total number of employees trained | % | 100 | 88 | ||
| R&D investment amount for Furaprevir (Phase III clinical trial) | RMB'000 | 42747.41 | 36 | ||
| R&D investment amount for Insulin Aspart 30 Injection | RMB'000 | 29795.58 | 37 | ||
| R&D investment amount for Insulin Glargine Injection | RMB'000 | 17903.1 | 37 | ||
| R&D investment amount for Isohpane Protamine Recombinant Human Insulin Injection (Pre-mixed 30R) | RMB'000 | 27383.85 | 37 | ||
| Total number of employees trained | Person | 4766 | 88 |
The average training hours completed per employee by gender and employee category.
| Indicator | Unit | 2019 | 2020 | 2021 | Report Pages |
|---|---|---|---|---|---|
| Average training hours for all employees | Hours | 41.9 | 36 | 89 | |
| Average training hours for entry-level employees | Hours | 38.17 | 89 | ||
| Average training hours for female employees | Hours | 34.66 | 89 | ||
| Average training hours for male employees | Hours | 36.85 | 89 | ||
| Average training hours for mid-level management | Hours | 9.54 | 89 | ||
| Average training hours for senior management | Hours | 15.07 | 89 | ||
| Average training hours of entry-level employees | hours | 38.17 | 67 | ||
| Average training hours of mid-level management | hours | 9.54 | 67 | ||
| Average training hours of senior management | hours | 15.07 | 67 | ||
| Average training hours per employee | hours | 35.66 | 67 | ||
| Completion rate of environmental protection knowledge training (oral solid dosage workshop departments) | 100% | 48 | |||
| Expensed R&D investment amount for Furaprevir (Phase III clinical trial) | RMB'000 | 29293.29 | 36 | ||
| Expensed R&D investment amount for Insulin Glargine Injection | RMB'000 | 1098.4 | 37 | ||
| Number of mid-level management trained | Person | 372 | 88 | ||
| Total training hours for all employees | Hours | 260529 | 169971 | 89 | |
| Total training hours for entry-level employees | Hours | 254503 | 165578 | 89 | |
| Total training hours for female employees | Hours | 89698 | 89 | ||
| Total training hours for male employees | Hours | 80273 | 89 | ||
| Total training hours for mid-level management | Hours | 4926 | 3549 | 89 | |
| Total training hours for senior management | Hours | 1100 | 844 | 89 | |
| Training hours of female employees | hours | 34.66 | 67 | ||
| Training hours of male employees | hours | 36.85 | 67 |
Number of suppliers by geographical region.
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Number of major suppliers | Suppliers | 607 | 718 | 89 |
| Number of major suppliers in Hubei province | Suppliers | 205 | 256 | 89 |
| Number of major suppliers in other regions in the PRC | Suppliers | 402 | 456 | 89 |
| Number of major suppliers overseas | Suppliers | 6 | 89 |
Number of products and service related complaints received and how they are dealt with.
| Indicator | Unit | 2019 | 2020 | 2021 | 2022 | Report Pages |
|---|---|---|---|---|---|---|
| Complaints related to product quality | Times | 1 | 90 | |||
| Other complaints | Times | 13 | 3 | 90 | ||
| Percentage change in the amount for the current period as compared to the same period last year for Furaprevir (Phase III clinical trial) | % | -58.47 | 36 | |||
| Percentage change in the amount for the current period as compared to the same period last year for Insulin Aspart 30 Injection | % | -18.69 | 37 | |||
| Percentage change in the amount for the current period as compared to the same period last year for Insulin Glargine Injection | % | -41.54 | 37 | |||
| Percentage change in the amount for the current period as compared to the same period last year for Isohpane Protamine Recombinant Human Insulin Injection (Pre-mixed 30R) | % | 8.33 | 37 |
Description of practices relating to observing and protecting intellectual property rights.
| Indicator | Unit | 2021 | 2022 | Report Pages |
|---|---|---|---|---|
| Number of filed manufacturers for Aripiprazole Orally Disintegrating Tablets | 7 | 40 | ||
| Number of filed manufacturers for Atorvastatin Calcium Tablets | 11 | 40 | ||
| Number of filed manufacturers for Clopidogrel Tablets | 8 | 40 | ||
| Number of filed manufacturers for Entacapone Tablets | 6 | 40 | ||
| Number of filed manufacturers for Febuxostat Tablets | 3 | 40 | ||
| Number of filed manufacturers for Metoprolol Succinate Sustained-release Tablets | 13 | 40 | ||
| Number of filed manufacturers for Solifenacin Tablets | 14 | 40 |
Focus areas of contribution (e.g. education, environmental concerns, labour needs, health, culture, sport).
| Indicator | Unit | 2020 | Report Pages |
|---|---|---|---|
| Number of participants in volunteer activities | Person | 39 | 91 |
Resources contributed (e.g. money or time) to the focus area.
| Indicator | Unit | 2019 | 2020 | Report Pages |
|---|---|---|---|---|
| Amount contributed for charity | Ten thousand (RMB) | 30 | 100 | 91 |
Direct (Scope 1) and energy indirect (Scope 2) greenhouse gas emissions (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2020 |
|---|---|---|
| Direct GHG Emissions (Scope 1) | tonnes | 46.67 |
| Indirect Energy Emissions (Scope 2) | tonnes | 42480.75 |
| Total GHG Emissions | tonnes CO2e | 42527.43 |
| Total GHG Emissions Intensity (By Revenue) | tonnes CO2e/RMB million | 18.11 |
Total hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2020 |
|---|---|---|
| Total Hazardous Waste | Tonnes | 78.69 |
| Total Hazardous Waste Intensity (By Revenue) | Tonnes/revenue (RMB million) | 0.03 |
Total non-hazardous waste produced (in tonnes) and, where appropriate, intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2020 |
|---|---|---|
| Non-Hazardous Waste Disposed | Tonnes | 1737.51 |
| Total Non-Hazardous Waste Intensity (By Revenue) | Tonnes/revenue (RMB million) | 0.74 |
Direct and/or indirect energy consumption by type (e.g. electricity, gas or oil) in total (kWh in '000s) and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Diesel Fuel Consumption | Litres | 19060 | 17880 |
| Energy Consumption Intensity (By Revenue) | Tonnes of standard coal/revenue (RMB million) | 1.86 | 5.53 |
| Purchased Electricity | kWh | 33231342 | 5267284 |
| Purchased Steam | Tonnes | 58294.48 | 50902.6 |
| Total Energy Consumption | Tonnes of standard coal | 11630.85 | 12991.35 |
Water consumption in total and intensity (e.g. per unit of production volume, per facility).
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Discharge of Industrial Wastewater | Tonnes | 1064987.23 | |
| Water Consumption | Tonnes | 529377 | 1273174.3 |
Total packaging material used for finished products (in tonnes) and, if applicable, with reference to per unit produced.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Packaging Materials Consumed | tonnes | 3116.7 | 2090.93 |
Description of the significant impacts of activities on the environment and natural resources and the actions taken to manage them.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Total Investment in Ecological Restoration | RMB | 5295373 | 7143078 |
Total workforce by gender, employment type (for example, full- or part-time), age group and geographical region.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Number of Employees Aged 30-50 | Person | 3796 | 3296 |
| Number of Employees Aged Above 50 | Person | 62 | 74 |
| Number of Employees Aged Below 30 | Person | 2354 | 1396 |
| Number of Employees in Mainland China | Person | 1997 | 4478 |
| Number of Employees in Overseas | Person | 2 | |
| Number of Female Employees | Person | 2467 | 2588 |
| Number of Male Employees | Person | 3745 | 2178 |
| Number of Total Employees | Person | 6212 | 4766 |
| Percentage of Employees Aged 30-50 | % | 61.1 | 69.1 |
| Percentage of Employees Aged Above 50 | % | 1 | 1.6 |
| Percentage of Employees Aged Below 30 | % | 37.9 | 29.3 |
| Percentage of Female Employees | % | 39.7 | 54.3 |
| Percentage of Male Employees | % | 60.3 | 45.7 |
Employee turnover rate by gender, age group and geographical region.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Turnover Rate of Employees Aged 30-50 | % | None | None |
| Turnover Rate of Employees Aged Above 50 | % | None | None |
| Turnover Rate of Employees Aged Below 30 | % | None | None |
| Turnover Rate of Employees in Central China | % | None | None |
| Turnover Rate of Total Employees | % | 3.6 | 23.28 |
Lost days due to work injury.
| Standard Indicator | Unit | 2019 |
|---|---|---|
| Lost Days Due to Work-related Injuries | Days | 126 |
The percentage of employees trained by gender and employee category (e.g. senior management, middle management).
| Standard Indicator | Unit | 2020 |
|---|---|---|
| Percentage of Employees Trained | % | 100 |
| Percentage of New Employees Trained | % | 91.02 |
| Percentage of Trained Female Employees | % | 54.3 |
| Percentage of Trained Male Employees | % | 45.7 |
| Percentage of Trained Middle Management | % | 7.81 |
| Percentage of Trained Senior Management | % | 1.17 |
The average training hours completed per employee by gender and employee category.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Average Training Hours (Female) | Hours | 34.66 | |
| Average Training Hours (Male) | Hours | 36.85 | |
| Average Training Hours (Middle Management) | Hours | 9.54 | |
| Average Training Hours (Senior Management) | Hours | 15.07 | |
| Average Training Hours per Employee | hours | 41.9 | 35.66 |
| Total Training Hours | Hours | 260529 | 169971 |
Number of suppliers by geographical region.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Number of Suppliers in Mainland China | Suppliers | 607 | 712 |
| Number of Suppliers in Overseas | Suppliers | 6 | |
| Number of Total Suppliers | Suppliers | 607 | 718 |
Number of products and service related complaints received and how they are dealt with.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Number of Product Quality Complaints | Times | 1 | |
| Number of Products and Service Related Complaints | Times | 1 | |
| Total Number of Customer Complaints | Times | 13 | 4 |
Resources contributed (e.g. money or time) to the focus area.
| Standard Indicator | Unit | 2019 | 2020 |
|---|---|---|---|
| Total Public Welfare Donations | Ten thousand (RMB) | 30 | 100 |
| Total Social Investment | Ten thousand (RMB) | 30 | 100 |